[1
]
Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Department
of Internal Medicine, Department of Molecular Pharmacology & Experimental Therapeutics,
Department of Medical Genetics, Mayo Clinic, 200 First St. SW, Rochester, MN, USA;
Institute of Theoretical and Experimental Biophysics, Russian Academy of Science,
Institutskaya 3, Pushchino, Moscow Region 142290, Russia. Electronic address: alekseev.alexey@mayo.edu.
[2
]
Univ. Grenoble Alpes, Laboratory of Fundamental and Applied Bioenergetics (LBFA),
and SFR Environmental and Systems Biology (BEeSy), Grenoble, France; Inserm, U1055,
Grenoble, France.
[3
]
Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Department
of Internal Medicine, Department of Molecular Pharmacology & Experimental Therapeutics,
Department of Medical Genetics, Mayo Clinic, 200 First St. SW, Rochester, MN, USA.
[4
]
Univ. Grenoble Alpes, Laboratory of Fundamental and Applied Bioenergetics (LBFA),
and SFR Environmental and Systems Biology (BEeSy), Grenoble, France; Inserm, U1055,
Grenoble, France; Clinique Universitaire de Pneumologie, Pôle Thorax et Vaisseaux,
Centre Hospitalier et Universitaire des Alpes, CS10217, 38043 Grenoble Cedex 9, France.
[5
]
Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat
de Barcelona, and IBUB Barcelona, Gran Via de les Corts Catalanes 585, 08007 Barcelona,
Spain.
[6
]
Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat
de Barcelona, and IBUB Barcelona, Gran Via de les Corts Catalanes 585, 08007 Barcelona,
Spain. Electronic address: martacascante@ub.edu.